| Authors: |
DeBerg HA; Center for Systems Immunology, Benaroya Research Institute (BRI) at Virginia Mason, Seattle, Wash., Baloh CH; Immune Tolerance Network, BRI at Virginia Mason, Seattle, Wash; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass., DeGottardi Q; Center for Translational Immunology, BRI at Virginia Mason, Seattle, Wash; Seattle Children's Research Institute, Seattle, Wash., Hou J; Center for Translational Immunology, BRI at Virginia Mason, Seattle, Wash; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Wash., Johansson A; Center for Translational Immunology, BRI at Virginia Mason, Seattle, Wash., Newell E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Wash., Laidlaw TM; Immune Tolerance Network, BRI at Virginia Mason, Seattle, Wash; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass., Sanda S; Immune Tolerance Network, BRI at Virginia Mason, Seattle, Wash; Division of Endocrinology, UCSF Diabetes Center, UCSF School of Medicine, University of California, San Francisco, Calif., Shamji M; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London, United Kingdom., Durham S; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London, United Kingdom., Togias A; The National Institute of Allergy and Infectious Disease, Bethesda, Md., Kwok WW; Center for Translational Immunology, BRI at Virginia Mason, Seattle, Wash; Division of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle, Wash. Electronic address: bkwok@benaroyaresearch.org. |
